Physician

Benjamin D Rosenbluth, M.D.

According to 2025 Medicare claims, Benjamin Rosenbluth, M.D. (NPI: 1013930007) practices radiation oncology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is RADIATION ONCOLOGY PARTNERS PC (NPI: 1962412742; TIN: 201104758) and primary practice location at 07666-4245. Rosenbluth is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Rosenbluth's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 95 traditional Medicare patients, billed 777 HCPCS/CPT codes, and received $92,911 in Medicare payments. The top billing code was 77427 (Radiation treatment management, 5 treatment sessions). Part D data shows 96 prescription claims across 43 beneficiaries totaling $1,332 in drug costs, led by Methylprednisolone (Methylprednisolone). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $189,794 to $92,911. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $2,418 and ending at $1,332. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$101K$202K2015 Medicare payment: $189,794 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $176,980 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $202,215 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $181,244 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $190,543 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $162,283 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $138,121 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $138,872 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $152,031 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $92,911 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152182,164$189,794
20162101,977$176,980
20172102,328$202,215
20182172,167$181,244
20191821,999$190,543
20201381,527$162,283
20211251,303$138,121
20221311,275$138,872
20231741,442$152,031
202495777$92,911

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$4.6K$9.3K2015 Drug cost: $2,418 (USD; Tot_Drug_Cst)2016 Drug cost: $2,168 (USD; Tot_Drug_Cst)2017 Drug cost: $3,072 (USD; Tot_Drug_Cst)2018 Drug cost: $7,142 (USD; Tot_Drug_Cst)2019 Drug cost: $1,841 (USD; Tot_Drug_Cst)2020 Drug cost: $2,878 (USD; Tot_Drug_Cst)2021 Drug cost: $2,937 (USD; Tot_Drug_Cst)2022 Drug cost: $3,512 (USD; Tot_Drug_Cst)2023 Drug cost: $9,296 (USD; Tot_Drug_Cst)2024 Drug cost: $1,332 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154299$2,418
20163681$2,168
201746114$3,072
20183874$7,142
201937103$1,841
20203279$2,878
20213887$2,937
202251123$3,512
202372176$9,296
20244396$1,332

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
77427Radiation treatment management, 5 treatment sessions3392$159
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more3737$149
77290Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved4043$69
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more3642$54
77334Design and construction of complex radiation treatment device4583$51

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MethylprednisoloneMethylprednisolone37226$329
Sildenafil CitrateSildenafil Citrate12360$66

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Benjamin D. Rosenbluth, M.D.?

Tedicare shows public-source Medicare data for Benjamin D. Rosenbluth, M.D. (NPI 1013930007), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Benjamin D. Rosenbluth, M.D. have ACO affiliation data?

Benjamin D. Rosenbluth, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Benjamin D. Rosenbluth, M.D.?

Benjamin D. Rosenbluth, M.D. is linked to RADIATION ONCOLOGY PARTNERS PC (billing NPI 1962412742) in the available physician profile data.

Does Benjamin D. Rosenbluth, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.